Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | PT217 |
Synonyms | |
Therapy Description |
PT217 is a bispecific antibody that targets DLL3 and CD47, potentially resulting in enhanced tumor cell phagocytosis and inhibition of tumor growth (Cancer Res (2022) 82 (12_Supplement): 2908). |